Both aging and inappropriate secretion of aldosterone increase the risk for developing cardiovascular disease; however, the influence of aging on aldosterone secretion and physiology is not well understood.
A ldosterone is a major physiological regulator of intravascular volume and blood pressure. However, inappropriate aldosterone secretion and excessive mineralocorticoid receptor activation result in cardiovascular disease. [1] [2] [3] [4] The overall capacity to produce aldosterone chronically relies on aldosterone synthase (cytochrome P450, family 11, subfamily B, polypeptide 2 [CYP11B2]). 5 In normal physiology, CYP11B2 is found in the zona glomerulosa (ZG) of the adrenal cortex, and its expression is tightly regulated by the renin-angiotensin II system and circulating potassium (K + ). Both angiotensin II (Ang II) and K + increase intracellular calcium signaling as a primary pathway to regulate aldosterone production. [5] [6] [7] [8] [9] [10] Prior human studies with small sample sizes have suggested that older individuals may secrete less aldosterone than younger ones [11] [12] [13] [14] [15] ; however, the dynamic of aldosterone physiology across the entire age continuum has not been studied in depth. Furthermore, corresponding age-related changes to the adrenal ZG or expression of CYP11B2 have not been studied.
Specific antibodies to CYP11B2 were recently generated 16, 17 and used to identify aldosterone-producing cells in both normal adrenal glands and tumors. [18] [19] [20] [21] [22] With the use of these antibodies, >50% of morphologically normal adrenal glands were found to have abnormal foci of CYP11B2-expressing cells in addition to normal CYP11B2 expression in ZG. These aldosterone-producing cell clusters (APCCs) have been shown to penetrate into the zona fasciculata, 16, 17 harbor somatic mutations that are known to increase aldosterone secretion, and appear to secrete aldosterone in a renin-and Ang II-independent manner. 22 In this regard, APCCs are now considered to be a previously unrecognized source of autonomous aldosterone secretion and a possible precursor to or attenuated form of primary aldosteronism. 23 We hypothesized that the process of aging could be associated with an increase in the amount of adrenal APCCs and, therefore, a resulting concomitant decrease in physiological CYP11B2 expression in the ZG. Furthermore, we hypothesized that these age-related histopathologic changes may result in greater autonomous aldosterone secretion (renin-independent aldosteronism) and a concomitant failure to physiologically stimulate aldosterone.
METHODS

Normal Human Adrenal Samples
Human adrenal glands were obtained from renal transplantation donors at Georgia Regents University and the University of Michigan. All donors of adrenal glands or their families provided informed consent, and the use of these adrenal glands was approved by the institutional review boards of the University of Michigan and Georgia Regents University. Formalin-fixed paraffin-embedded tissue blocks of 127 adrenal glands without overt pathological findings were used for CYP11B2 immunohistochemistry and hematoxylin and eosin staining.
Immunohistochemistry
Formalin-fixed paraffin-embedded sections were cut at a thickness of 5 µm and rehydrated to water. Heat-induced epitope retrieval was performed with FLEX TRS High pH Retrieval buffer (Dako) for 20 minutes. After peroxidase blocking, the CYP11B2 mouse monoclonal antibody (clone 41-17B, #MABS1251, Millipore) 16 was applied at a dilution of 1:1500 at room temperature for 60 minutes. The FLEX HRP Envision System (Dako) was used for detection. Diaminobenzidine chromagen was then applied for 10 minutes. Slides were counterstained with Harris hematoxylin for 5 seconds and then dehydrated and coverslipped.
Quantification of CYP11B2 Expression
Digital images of CYP11B2 immunohistochemistry were captured for each adrenal gland by using PathScan Enabler IV (Meyer Instruments, Inc). Intact adrenal cortex regions on each scanned image were cropped, guided by hematoxylin and eosin slides, and analyzed by using ImageJ software (US National Institutes of Health). The ImageJ threshold tool was used for analyzing area of the adrenal cortex and CYP11B2-expressing areas. Representative images of quantification analysis are shown in online-only Data Supplement Figure  I . The areas of APCC were quantified by using the ImageJ drawing tool. In the present study, the CYP11B2-expressing foci were considered as APCC when they met both of the
Clinical Perspective
What Is New?
• This study demonstrates a progressive pattern of abnormal aldosterone physiology with aging.
• Adrenal glands from older individuals displayed less normal aldosterone synthase (CYP11B2) expression in the zona glomerulosa and greater content of abnormal foci of CYP11B2-expressing cells.
• Older age was independently associated with dysregulated and autonomous aldosterone physiology in an ancillary clinical study of subjects without primary aldosteronism.
What Are the Clinical Implications?
• The results provide a better understanding of agerelated aldosterone physiology and one potential explanation for age-related cardiovascular risk.
• The study suggests that aging may be associated with a subclinical form of aldosterone excess.
• Moreover, our findings suggest that a substantial proportion of age-related hypertension may be impacted by pathophysiologic aldosterone secretion, and, therefore, mineralocorticoid receptor antagonist therapy may be a therapeutic option.
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following criteria: (1) CYP11B2-expressing foci composed of subcapsular ZG cells that penetrated into the zona fasciculata, and (2) area >0.025 mm 2 . CYP11B2-expressing area/adrenal cortex area, sum of APCC areas/adrenal cortex area, and sum of APCC areas/CYP11B2-expressing area were then calculated. Normal ZG CYP11B2-expressing area was also assessed by subtracting the sum of APCC areas from total CYP11B2-expressing area followed by normalization to the adrenal cortex area. Lengths of continuous CYP11B2-expressing ZG and total ZG in examined adrenal cortex were also measured by using the ImageJ drawing tool. The adrenal gland was considered as having continuous CYP11B2 expression if the ratio of continuous CYP11B2-expressing ZG length to total ZG length was >50%. If the ratio was ≤50%, the adrenal gland was considered to have discontinuous CYP11B2 expression.
Assessment of Aldosterone Physiology With Aging in Humans
In parallel to the aforementioned histopathologic studies, we conducted cross-sectional studies of human subjects that underwent detailed protocols to phenotype the reninangiotensin-aldosterone system in the HyperPATH study (International Hypertension Pathotype). The details of the HyperPATH cohort and study protocol have been previously described in detail. 24 Although results from the HyperPATH cohort have been previously reported, the present studies investigating age as an independent predictor of reninangiotensin-aldosterone system activity are original. In brief, HyperPATH is an on-going, multi-institutional cohort dedicated to study hormonal mechanisms of hypertension and cardiovascular disease. Normotensive and stage I hypertensive participants were recruited and withdrawn from all antihypertensive medications for 1 to 3 months before the study, as previously described. 24 All subjects were then studied under 2 dietary conditions, sodium restriction and sodium loading, 1 week apart from each other. Sodium restriction was achieved by providing subjects with a diet containing 10 mmol/d sodium, 100 mmol/d potassium, and 20 mmol/d calcium for 5 to 7 days. Sodium loading was achieved by providing subjects with a diet containing ≈200 mmol/d sodium, 100 mmol/d potassium, and 20 mmol/d calcium for 5 to 7 days. Every subject completed a 24-hour urine collection on the final day of the study diet. After completing each dietary period, subjects were admitted to the Clinical Research Center and kept in a supine posture overnight. The following morning, after 12 hours of supine posture, measurements of plasma renin activity (PRA) and serum aldosterone were obtained.
In the current study, we included only those HyperPATH participants who demonstrated compliance with the dietary sodium interventions as assessed via 24-hour urinary sodium excretion. Subjects had to achieve a high sodium balance when sodium loaded (≥150 mmol/d) and a low sodium balance when sodium restricted (≤40 mmol/d). Furthermore, we excluded any participants who may have had unrecognized primary aldosteronism. Participants were excluded if they had a 24-hour urinary aldosterone excretion rate >12 μg in the setting of a 24-hour urinary sodium excretion >200 mmol with a PRA<1.0 ng/mL×h, or if they had a 24-hour urinary aldosterone excretion rate of >10 μg in the setting of a 24-hour urinary sodium excretion of >150 mmol with a PRA <1.0 ng/mL×h and an aldosterone-to-renin ratio (ARR) of >20 ng/dL per ng/mL×h. The sample size for the current study after using these criteria was 677. All participants provided informed consent, and the protocol was monitored by the institutional human ethics and research committee at Brigham and Women's Hospital.
Laboratory Assays
Duplicate measures of PRA (Diasorin) and serum aldosterone (Siemens) were obtained in the morning at ≈7 to 8 am in the supine position. Duplicate measurements were averaged, and the mean was used in analyses.
Statistical Analysis
We used Pearson correlation coefficients to describe the association between age and CYP11B2-expressing areas. Multivariable linear regression modeling was also used for the analysis with adjustments for sex and race (white and black, n=116). Population characteristics for adrenal glands with and without APCC were compared by using a MannWhitney U test. A χ 2 test was used for comparison of categorical variables. In the clinical study, we assessed the association between age (independent variable) and aldosterone and PRA (dependent variables) using multivariable linear regression. To assess renin-independent aldosteronism, we used the ARR metric (serum aldosterone divided by PRA). To assess dysregulated aldosterone physiology, we used the sodiummodulated aldosterone suppression-to-stimulation index (SASSI). The SASSI is calculated by dividing serum aldosterone under sodium-loaded conditions (maximally suppressed aldosterone) by the serum aldosterone under sodium-restricted conditions (maximally stimulated aldosterone). Prior studies have shown that the SASSI reflects the full range of aldosterone physiology, whereby a lower SASSI suggests normal aldosterone physiology, and a higher SASSI indicates abnormal aldosterone physiology. 25, 26 Linear regression models were adjusted for sex, race, body mass index, 24-hour urinary sodium excretion, mean arterial blood pressure, and hypertension status. Results were presented as effect estimates (β) with corresponding P values. The ARR and SASSI were log transformed only when presented for graphical purposes for ease of presentation. Statistical analyses were performed using SigmaPlot 12.5 (Systat Software, Inc) and SAS v9.4. A 2-tailed P value of <0.05 was considered significant.
RESULTS
Relationship Between CYP11B2 Expression Patterns and Age in Normal Adrenal Glands
A total of 127 normal adrenal glands ranging in age from 9 months old to 68 years old were used for CYP11B2 immunohistochemistry, followed by imaging analysis. Characteristics of donor adrenal glands are summarized in Table 1 . Of 127 adrenal glands, 88 (69%) had at least 1 APCC, and the earliest documentation of APCC was in a 12-year-old boy. Representative CYP11B2 expres-sion patterns of young versus older age adrenal glands are shown in Figure 1 . Continuous CYP11B2 expression in ZG was more frequently observed in young adrenal glands than that seen in older adrenal glands ( Figure 1A through 1C) , and many older-age adrenal glands showed discontinuous or no ZG CYP11B2 expression ( Figure 1D through 1G) . In image analysis, the total CYP11B2-expressing area normalized to adrenal cortex was negatively correlated with age (r=−0.431, P<0.0001, Figure 2A) , and the normal ZG CYP11B2-expressing area, calculated by subtracting APCC areas from total CYP11B2-expressing area, was also negatively correlated with age (normalized to adrenal cortex, r=−0.495, P<0.0001, Figure 2B) . However, the sum of APCC areas normalized to adrenal cortex exhibited a positive correlation with age (r=0.390, P<0.0001, Figure 2C ). The integrated ratio of APCC area to total CYP11B2-expressing area was also positively correlated with age (r=0.587, P<0.0001, Figure 2D ), suggesting a Adrenal gland with at least 1 APCC, n/% 88/69%
APCC indicates aldosterone-producing cell cluster. * Median (interquartile range). 
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transition from ZG CYP11B2 expression predominance in young age to APCC predominance with older age. The association between age and the ratio of APCC area to total CYP11B2-expressing area remained significant after adjustment for sex and race (β=+0.589,
P<0.001).
We further compared CYP11B2 expression patterns between adrenal glands with and without APCC (Table 2). As expected, donor age was significantly older in adrenal glands with at least 1 APCC in comparison with those without APCC (P<0.001). Prevalence of continuous ZG CYP11B2 expression, total CYP11B2-expressing area normalized to adrenal cortex, and normal ZG CYP11B2-expressing area normalized to adrenal cortex were significantly lower in adrenal glands with APCC than those without APCC (P<0.001, P=0.049, and P<0.001, respectively).
Dynamic Aldosterone Dysregulation and Age
Participants in the clinical study ranged in age from 18 to 71 years, with a mean age of 44.7 (11.8), and consisted mostly of white men. When participants were studied under a high sodium balance, mean supine PRA was 0.56 (0.77) ng/mL×h and mean supine serum aldosterone was 4.8 (3.5) ng/dL (Table 3 ). There was an inverse association between age and PRA (β=−0.075 ng/mL per hour per 10 years, P<0.01). However, even though PRA decreased with older age, serum aldosterone (β=−0.14 ng/dL aldosterone per 10 years, P=0.24) and 24-hour urinary aldosterone excretion (β=−0.30 μg of aldosterone per 24 hours per 10 years, P=0.31) did not significantly change with age (Table 3) . Correspondingly, the ARR was higher with older age (β=+3.88 ng/dL per ng/mL per hour per 10 years, P=0.001) ( Figure 3A) . The association between age and ARR remained significant after adjustments for sex, race, body mass index, blood pressure, hypertension status, and urinary sodium excretion (β=+5.54 U per 10 years, P<0.001).
The same participants were sodium restricted to assess the stimulation of the renin-angiotensin-aldosterone system, resulting in the rise of the mean supine PRA to 3.07 (4.08) ng/mL per hour and the mean supine serum aldosterone to 19.2 (13.1) ng/dL. In this context, we observed a blunted stimulation of both PRA and aldo- Figure 2 . CYP11B2 expression patterns in normal human adrenals across aging. A, Correlation between age and total CYP11B2-expressing area normalized to adrenal cortex area (%). B, Correlation between age and normal zona glomerulosa CYP11B2-expressing area (%). Normal zona glomerulosa CYP11B2-expressing area was calculated by subtracting APCC areas from total CYP11B2-expressing area. C, Correlation between sum of APCC areas normalized to adrenal cortex (%). D, Correlation between age and ratio of APCC area to total CYP11B2-expressing area (%). APCC indicates aldosterone-producing cell cluster.
sterone with older age (PRA: β=−0.54 ng/mL×h per 10 years, P<0.01; and aldosterone: β=−4.6 ng/dL per 10 years, P<0.0001).
Given evidence of both nonsuppressible renin-independent aldosteronism and impaired stimulation of aldosterone with older age, we integrated these physiological responses into a single metric: the SASSI. Using the SASSI to capture the full spectrum of dysregulated aldosterone physiology, we observed a positive association between older age and higher SASSI ( Figure 3B ) (unadjusted β=0.072, P<0.0001) that remained significant after adjustments for sex, race, body mass index, mean arterial blood pressure, hypertension status, and urinary sodium excretion (β=0.037, P<0.01).
DISCUSSION
Herein, we demonstrate histopathologic and clinical evidence that suggests a progressive pattern of abnormal aldosterone physiology with aging. Young adrenal glands were found to display a pattern of normal CY-P11B2 expression. However, adrenal glands from older individuals displayed progressively less normal CYP11B2 expression and greater APCC content. In a separate hu- Values are medians with interquartile ranges for continuous variables and counts and frequencies for categorical variables. APCC indicates aldosterone-producing cell cluster; and ZG, zona glomerulosa. *The adrenal gland was considered as having continuous CYP11B2 expression if the ratio of continuous CYP11B2 expressing ZG length to total ZG length was >50%.
†Normal ZG CYP11B2-expressing area was calculated by subtracting APCC areas from total CYP11B2 expressing area. Values are means with standard deviations for normally distributed variables; means, and medians, as well, with interquartile ranges for nonnormally distributed variables; and counts and frequencies for categorical variables.
ORIGINAL RESEARCH ARTICLE man study, we observed that older age was independently associated with an inability to appropriately suppress aldosterone under conditions of sodium loading, and a concomitant inability to appropriately stimulate aldosterone with sodium restriction. Taken together, these findings suggest that histopathologic changes to adrenal CYP11B2 and progressive dysregulated aldosterone physiology may be age-dependent phenomena. These observations may not only have important implications in our understanding of age-related aldosterone physiology, but also in regard to public health, because inappropriate aldosterone secretion might be a common modifiable risk factor for age-related cardiovascular disease.
The human adrenal gland undergoes significant remodeling over the course of a lifetime. 27 Immediately after birth, cells within the adrenal fetal zone undergo apoptosis. 28 During the neonatal period, elevated plasma aldosterone concentration with incomplete renal tubular responsiveness to aldosterone has been documented. 29, 30 Under the influence of the trophic hormones Ang II and corticotropin, the adult ZG and zona fasciculata mature. 27 However, little is known about structural changes in the aging adrenal gland. Our results demonstrate that, overall, the adrenal cortex ZG CYP11B2-expressing area decreases with age. It is interesting that many of the young adrenal glands showed a ZG with continuous CYP11B2 expression, whereas older adrenal glands had more discontinuous CYP11B2 expression (Figure 1) . One potential explanation for these findings is that a decreased normal CYP11B2-expressing ZG results from a suppression of renin and Ang II because of autonomous and constitutive aldosterone secretion from APCCs. Our results show a clear increase in the APCC-to-CYP11B2 ratio with older age and decreased normal ZG CYP11B2 expression in adrenal glands with APCC. Aldosterone production from APCCs is suspected to be renin independent for the following reasons: (1) APCCs are observed even in the normal adrenal tissue that is adjacent to an aldosterone-producing adenoma, where circulating renin and Ang II levels are suppressed 18, 19, 31 ; and (2) many APCCs harbor the same aldosterone-stimulating somatic mutations as aldosterone-producing adenomas, including calcium channel, voltage-dependent, L-type, α1D-subunit (CACNA1D) and ATPase, Na + /K + transporting, α1-polypeptide (ATP1A1). 22 We hypothesized that the biochemical phenotype associated with APCCs could be 2-fold: (1) the autonomous aldosterone secretion from APCCs would manifest as suppression of renin in the presence of nonsuppressible aldosterone secretion (renin-independent aldosterone secretion); and (2) the inhibition of physiological renin and Ang II by this source of autonomous aldosterone secretion would not only decrease expression of normal ZG CYP11B2, but also decrease physiological aldosterone stimulation capacity. Indeed, the clinical observations in the current study reflect this hypothesized pattern by demonstrating higher ARR (renin-independent aldosteronism) with older age, and dysregulated aldosterone physiology (higher SASSI) with older age (failure to adequately suppress aldosterone despite lower PRA with sodium loading and failure to adequately stimulate aldosterone with sodium restriction). Human studies with relatively small sample sizes have previously suggested that older age may be The relationship between age and the aldosterone-to-renin ratio under sodium-loading conditions. For graphical purposes, the aldosterone-to-renin ratio is log transformed. B, The relationship between age and the sodium-modulated aldosterone suppression-to-stimulation index (SASSI). For graphical purposes, the SASSI is log transformed. The solid green line represents the mean regression and is surrounded by dashed green lines that represent the 95% confidence intervals for the mean regression. The dotted green lines represent the 95% confidence intervals for the observed values. associated with lower aldosterone secretion. [11] [12] [13] [14] [15] The present study extends these findings by studying a very large sample size with a wide range in age, and by deemphasizing focus on absolute aldosterone levels and rather focusing on characterizations of aldosterone and renin in relation to their expected or anticipated physiological responses.
It is important to note that we conducted 2 separate studies, and, therefore, our histopathologic and physiological observations are not linked directly. The lack of clinical and biochemical information of donors is also a limitation of the present study. Recent human studies have suggested that autonomous aldosterone secretion, and even overt primary aldosteronism, may be prevalent in normotensive individuals with a normal ARR. 32, 33 Therefore, biochemical profiling of the adrenal donors may have provided the ability to correlate our pathological findings with evidence of aldosterone autonomy that could have supported a causal link between APCCs and aldosterone secretion. However, our histopathologic and clinical findings were independently consistent with our overarching hypothesis and provide a rational proposition for a clinicopathologic continuum of autonomous aldosterone secretion. Last, all our analyses were cross sectional and therefore cannot determine the causality of relationships. However, even though causality between age and aldosterone autonomy may not be confirmed, the fact that older age is strongly associated with dysregulated aldosterone still has important clinical implications for future investigations. As a result of small sample size, differences between white and black adrenal CYP11B2 expression patterns could not be addressed. Because past studies have shown increased sensitivity to aldosterone, and a higher prevalence of low renin hypertension in blacks, as well, [34] [35] [36] racial differences will need to be addressed in future studies.
In conclusion, we observed notable changes in CY-P11B2 expression patterns with older age and corresponding age-related changes in renin and aldosterone physiology. Our findings suggest that aging is associated with a shift from predominantly normal CYP11B2 expression to a pattern predominant of APCCs. These histopathologic changes may explain the observed renin-independent aldosteronism and dysregulated aldosterone physiology that is prevalent with older age. Our findings provide a potentially unified explanation for the associations between aging and mineralocorticoid receptor over activation with cardiovascular disease, and further suggest that the effectiveness of mineralocorticoid receptor antagonists in older populations warrants more dedicated study.
